About US
Contact us
-
Volasertib​, Boehringer Ingelheim'​s Investigat​ional Oncology Compound, is Granted Orphan Drug Designatio​n for Acute Myeloid Leukemia in the US and EUBoehringer Ingelheim Pharmaceuticals, Inc. has announced that FDA and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML). Volasertib is cur2014/4/21
-
Newly minted GlaxoSmithKline diabetes drug faces formidable foes in GLP-1 marketThere's a new kid on the diabetes block. GlaxoSmithKline's ($GSK) albiglutide, now dubbed Tanzeum for the U.S. market, nabbedFDAapproval Tuesday. Now, the drug will go up against a triad of other GL2014/4/21
-
BioAlliance Pharma and Topotarget join forces to create new orphan oncology companyBioAlliance Pharma and Topotarget have announced a merger agreement with an aim to create an orphan oncology company with increased scale and a highly complementary pipeline of late-stage products tar2014/4/18
-
FDA approves GSK's Tanzeum injection for type 2 diabetes treatmentThe US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Tanzeum (albiglutide) subcutaneous injection to improve glycaemic control, along with diet and exercise, in adults with t2014/4/18
-
Janssen's prostate cancer drug Zytiga now available in Trinidad and TobagoThe Chemistry, Food & Drugs Division of the Trinidad and Tobago Ministry of Health has approved Janssen's first orally administered androgen synthesis inhibitor (testosterone) medication 'Abirater2014/4/17
-
Merck obtains FDA approval for grass pollen allergy drugMerck has obtained approval from the US Food and Drug Administration (FDA) for its Grastek (Timothy grass pollen allergen extract) sublingual tablet as immunotherapy for treatment of grass pollen-indu2014/4/17
-
Astellas European Foundation awards 2014 urology grant to Austrian and Swiss researchersThe Astellas European Foundation has awarded $150,000 under the 2014 Functional Urology and Uro-Gynaecology Grant to Dr Marianne Gamper for conducting a study, which will be undertaken in Austria and2014/4/16
-
GSK faces criminal investigation over bribery allegations in PolandUK-based drug manufacturer GlaxoSmithKline (GSK) is facing allegations of bribing doctors to promote its asthma drug Seretide in Poland's Lodz region. The issue, reported by BBC on its Panorama progr2014/4/16
-
Impax Pharma resubmits NDA to FDA for Parkinson's treatment RytaryImpax Laboratories division Impax Pharmaceuticals has resubmitted its new drug application (NDA) for Rytary (IPX066) to the US Food and Drug Administration (FDA) for treatment of patients with Parkins2014/4/15
-
Tetra and Stanley Center collaborate to discover next generation of schizophrenia drugsUS-based Tetra Discovery Partners entered into a drug development collaboration with the Broad Institute's Stanley Center for Psychiatric Research in Cambridge, Massachusetts. The deal is focused on2014/4/15